Zhejiang Xinweishengke Biotechnology

Zhejiang Xinweishengke Biotechnology is a biopharmaceutical company focused on the research and development of mRNA-based vaccines and therapeutics. Based in Huzhou, China, the company utilizes a proprietary mRNA platform and advanced delivery technologies, such as lipid nanoparticles (LNPs), to create next-generation treatments. Their pipeline includes candidates for infectious diseases, such as COVID-19 and influenza, as well as therapeutic vaccines for various cancers. The company aims to establish a full-chain mRNA drug development capability from sequence design to large-scale manufacturing. By leveraging its technical expertise, Xinweishengke seeks to provide innovative solutions for global public health challenges and unmet medical needs in oncology.